Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2004Pediatric Blood & CancerOpen Access

Down syndrome, drug metabolism and chromosome 21

View Full Paper
Ask AI
Bookmark
Share

Authors

JTJeffrey W. TaubYGYubin Ge

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Taub et al. (2004) studied this question.

synapsesocial.com/papers/6a106ce45725bbd5cc60fd5ehttps://doi.org/10.1002/pbc.20092
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Accumulation of high levels of methotrexate polyglutamates in lymphoblasts from children with hyperdiploid (greater than 50 chromosomes) B-lineage acute lymphoblastic leukemia: a Pediatric Oncology Group study1992 · 144 citations
  2. 2Reduced Folate Carrier Expression in Acute Lymphoblastic Leukemia: A Mechanism for Ploidy but not Lineage Differences in Methotrexate Accumulation1999 · 118 citations
  3. 3Distinctive demography, biology, and outcome of acute myeloid leukemia and myelodysplastic syndrome in children with Down syndrome: Children's Cancer Group Studies 2861 and 2891.1998 · 306 citations
  4. 4The Role of Cytidine Deaminase and GATA1 Mutations in the Increased Cytosine Arabinoside Sensitivity of Down Syndrome Myeloblasts and Leukemia Cell Lines2004 · 81 citations